Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,643 | 2 | 54.8% |
| Travel and Lodging | $894.94 | 3 | 29.9% |
| Food and Beverage | $447.78 | 8 | 14.9% |
| Education | $11.92 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,643 | 2 | $0 (2020) |
| Genentech USA, Inc. | $1,053 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $137.26 | 3 | $0 (2018) |
| Celgene Corporation | $116.33 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $35.78 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $1,500 | 1 | Novartis Pharmaceuticals Corporation ($1,500) |
| 2018 | $1,334 | 9 | Genentech USA, Inc. ($1,053) |
| 2017 | $152.11 | 3 | Celgene Corporation ($116.33) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 01/23/2020 | Novartis Pharmaceuticals Corporation | LGK974 (Drug) | — | In-kind items and services | $1,500.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT | ||||||
| 10/26/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Travel and Lodging | In-kind items and services | $558.92 | General |
| Category: BioOncology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Travel and Lodging | In-kind items and services | $179.67 | General |
| Category: BioOncology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Travel and Lodging | Cash or cash equivalent | $156.35 | General |
| Category: BioOncology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Food and Beverage | In-kind items and services | $127.89 | General |
| Category: BioOncology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Food and Beverage | Cash or cash equivalent | $30.52 | General |
| Category: BioOncology | ||||||
| 07/18/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $68.63 | General |
| 07/18/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.41 | General |
| 07/09/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $39.22 | General |
| 01/23/2018 | Novartis Pharmaceuticals Corporation | WNT974 (Drug) | — | In-kind items and services | $143.25 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
| 03/30/2017 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $20.09 | General |
| 03/30/2017 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $15.69 | General |
| 03/15/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $116.33 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $1,500 | 1 |
| RESEARCH RELATED PUBLICATION SUPPORT | Novartis Pharmaceuticals Corporation | $143.25 | 1 |
About Roisin Connolly, MB
Roisin Connolly, MB is a Medical Oncology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1801063094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roisin Connolly, MB has received a total of $2,998 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "" ($1,643).
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Baltimore, MD
- Active Since 05/15/2008
- Last Updated 02/05/2013
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1801063094
Products in Payments
- LGK974 (Drug) $1,500
- Herceptin (Biological) $1,053
- WNT974 (Drug) $143.25
- Abraxane (Drug) $116.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Baltimore
Mario Eisenberger, M.d, M.D
Medical Oncology — Payments: $2.9M
Dr. Tanguy Seiwert, M.d, M.D
Medical Oncology — Payments: $622,422
Carole Miller, Md, MD
Medical Oncology — Payments: $587,841
Bruce Smith, M.d, M.D
Medical Oncology — Payments: $406,689
Carol Huff, M.d, M.D
Medical Oncology — Payments: $384,580
Leisha Emens
Medical Oncology — Payments: $252,501